Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$238M |
| 2 |
Johnson & Johnson
JNJ
|
+$224M |
| 3 |
MON
Monsanto Co
MON
|
+$219M |
| 4 |
AET
Aetna Inc
AET
|
+$215M |
| 5 |
Broadcom
AVGO
|
+$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$242M |
| 2 |
Microsoft
MSFT
|
+$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Home Depot
HD
|
+$188M |
| 5 |
Nike
NKE
|
+$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
SemiLEDS
LEDS
$16.2M
| $302K | ﹤0.01% |
86,170
-40,300
| -32% | -$141K |
|
|
MVO
2902
MV Oil Trust
MVO
$69.7M
| $301K | ﹤0.01% |
+48,359
| New | +$301K |
|
2903
SIFCO Industries
SIF
$44.8M
| $301K | ﹤0.01% |
39,300
-2,000
| -5% | -$15.3K |
|
|
MCF
2904
DELISTED
Contango Oil & Gas Co.
MCF
| $300K | ﹤0.01% |
32,100
-18,300
| -36% | -$171K |
|
|
EDN
2905
Edenor
EDN
$789M
| $299K | ﹤0.01% |
10,745
-353
| -3% | -$9.82K |
|
2906
Apollo Global Management
APO
$78B
| $297K | ﹤0.01% |
+15,334
| New | +$297K |
|
2907
Professional Diversity Network
IPDN
$7.87M
| $297K | ﹤0.01% |
+1,362
| New | +$297K |
|
2908
Urban One Class A
UONE
$64M
| $297K | ﹤0.01% |
100,600
+100
| +0.1% | +$295 |
|
|
SMTX
2909
DELISTED
SMTC Corporation
SMTX
| $297K | ﹤0.01% |
194,100
+23,000
| +13% | +$35.2K |
|
|
ABAC
2910
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $297K | ﹤0.01% |
82,175
+10,900
| +15% | +$39.4K |
|
2911
Douglas Dynamics
PLOW
$765M
| $296K | ﹤0.01% |
8,800
-144,303
| -94% | -$4.85M |
|
|
STRM
2912
DELISTED
Streamline Health Solutions
STRM
| $296K | ﹤0.01% |
15,780
+2,420
| +18% | +$45.4K |
|
2913
Mind CTI
MNDO
$24.2M
| $295K | ﹤0.01% |
119,900
-9,000
| -7% | -$22.1K |
|
|
BPMC
2914
DELISTED
Blueprint Medicines
BPMC
| $295K | ﹤0.01% |
10,500
-700
| -6% | -$19.7K |
|
2915
vTv Therapeutics
VTVT
$52.5M
| $294K | ﹤0.01% |
1,523
+298
| +24% | +$57.5K |
|
2916
Value Line
VALU
$364M
| $293K | ﹤0.01% |
15,000
+400
| +3% | +$7.81K |
|
2917
iRadimed
IRMD
$945M
| $292K | ﹤0.01% |
26,300
-19,600
| -43% | -$218K |
|
|
IDXG
2918
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $292K | ﹤0.01% |
6,642
-209
| -3% | -$9.19K |
|
2919
Moog Class B
MOG.B
$6.34B
| $291K | ﹤0.01% |
4,400
+200
| +5% | +$13.2K |
|
2920
Axcelis
ACLS
$2.71B
| $290K | ﹤0.01% |
19,950
-100,399
| -83% | -$1.46M |
|
2921
Intellicheck
IDN
$110M
| $287K | ﹤0.01% |
104,200
+59,700
| +134% | +$164K |
|
|
NGHC
2922
DELISTED
National General Holdings Corp
NGHC
| $287K | ﹤0.01% |
11,500
-104,900
| -90% | -$2.62M |
|
|
CNV
2923
DELISTED
CNOVA N.V.
CNV
| $284K | ﹤0.01% |
+51,800
| New | +$284K |
|
|
CBR
2924
DELISTED
CIBER Inc.
CBR
| $283K | ﹤0.01% |
447,700
+105,000
| +31% | +$66.4K |
|
|
VRML
2925
DELISTED
Vermillion, Inc.
VRML
| $281K | ﹤0.01% |
296,100
-6,400
| -2% | -$6.07K |
|